refractory CML

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . hormone refractory prostate cancer . relapsed refractory AML . refractory anemia . rituximab refractory follicular . refractory rituximab naive / CMLS . cml : Ph + CML . chronic myeloid leukemia CML . Mortgage Lenders CML . Michael Coogan CML . Compellent Technologies CML . NYSE Arca CML * *

Related by context. Frequent words. (Click for all words.) 67 chronic myeloid leukemia CML 63 chronic myelogenous leukemia CML 63 nilotinib 62 T#I mutation 60 Ph + ALL 60 metastatic renal cell carcinoma 60 chronic lymphocytic leukemia CLL 59 dasatinib 59 relapsed refractory 58 chronic HCV 58 arsenic trioxide 58 DLBCL 58 Alemtuzumab 58 hepatitis C HCV 57 gastrointestinal stromal tumors 57 malignant pleural mesothelioma 57 multidrug resistant 57 tyrosine kinase inhibitors 56 lupus nephritis 56 latent tuberculosis 56 systemic lupus erythematosus SLE 56 imatinib 56 PegIntron 56 acute myelogenous leukemia AML 56 melanoma tumors 56 S. aureus infections 56 cutaneous T cell 56 ponatinib 56 fludarabine 56 HCV infection 56 raltegravir 56 recurrent ovarian cancer 55 HCV infected 55 Ph + CML 55 idiopathic pulmonary fibrosis IPF 55 EGFR inhibitors 55 NNRTIs 55 glioblastoma multiforme GBM 55 nasopharyngeal cancer 55 EGFRvIII 55 myeloid 55 follicular lymphoma 55 relapsing remitting 55 ceftriaxone 55 immunomodulator 55 decitabine 55 chronic HCV infection 55 chronic myelogenous leukemia 55 WNV infection 55 rituximab 55 HCV genotype 1 55 LY# [003] 55 HGS ETR1 55 acute myeloid leukemia AML 55 NRTIs 55 organ transplant rejection 55 Jevtana 54 NRTI 54 Rituximab 54 omalizumab 54 cytogenetic response 54 potent antiviral 54 allogeneic stem cell 54 lymphoma CTCL 54 Acute Myeloid Leukemia AML 54 hematological cancers 54 disease modifying antirheumatic 54 strep bacteria 54 ifosfamide 54 Hepatitis C virus HCV 54 CMV infection 54 chronic HBV infection 54 medullary thyroid cancer 54 infliximab 54 angiogenesis inhibitor 54 drugs DMARDs 54 malignant gliomas 54 BCR ABL 54 anti TNF alpha 54 anticancer therapy 54 temozolomide 54 CMV disease 54 anakinra 54 immunomodulators 54 chronic myeloid leukemia 54 latent TB infection 54 resistant ovarian cancer 54 pneumococcal bacteria 53 tumor shrinkage 53 Erlotinib 53 FOLFIRI 53 isoniazid 53 xenograft models 53 bortezomib 53 androgen independent 53 B CLL 53 azacitidine 53 adefovir 53 advanced NSCLC 53 Chronic Hepatitis C 53 Trastuzumab

Back to home page